Systemic treatment in breast-cancer patients with brain metastasis

被引：37
|
作者：
Arslan, Cagatay [1 ]
Dizdar, Omer [1 ]
Altundag, Kadri [1 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, TR-0000 Ankara, Turkey
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2010年 / 11卷 / 07期
关键词：
CENTRAL-NERVOUS-SYSTEM; PHASE-II TRIAL; DOSE INTRAVENOUS METHOTREXATE; TEMOZOLOMIDE; WEEKS; PROGNOSTIC-FACTORS; SOLID TUMORS; CEREBROSPINAL-FLUID; RANDOMIZED-TRIAL; I/II TRIAL; LEPTOMENINGEAL METASTASIS;
D O I：
10.1517/14656561003702412
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Areas covered in this review: Standard therapy for brain metastasis is currently whole-brain radiotherapy. Other treatment modalities include surgery and radiosurgery in selected cases, corticosteroids, and systemic chemotherapy. Little progress has been made in chemotherapy for the treatment of brain metastases, partly because tumors develop brain metastases at a stage when they become totally chemoresistant. Nevertheless, new treatment choices have emerged considering cytotoxic and biological agents for the treatment of CNS metastases in patients with breast cancer. What the readers will gain: In this review, we aimed to review current and future treatment options in the systemic treatment of brain metastases of breast cancer. Take home message: Corticosteroids, anti-epileptic drugs, and radiotherapy remain the cornerstones of management. The efficacy of conventional cytotoxic chemotherapeutics is limited. Novel biologic agents, lapatinib being the most promising, are currently investigated in the treatment of brain metastases of breast cancer with promising results.
引用
收藏
页码：1089 / 1100
页数：12
相关论文
共 50 条
  • [11] ADJUVANT SYSTEMIC TREATMENT AND THE PATTERN OF RECURRENCES IN PATIENTS WITH BREAST-CANCER
    KAMBY, C
    ROSE, C
    EJLERTSEN, B
    ANDERSEN, J
    BIRKLER, NE
    RYTTER, L
    ANDERSEN, KW
    ZEDELER, K
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (03): : 439 - 447
  • [12] OCULAR PENETRATION OF TAMOXIFEN IN PATIENTS ON SYSTEMIC TREATMENT FOR BREAST-CANCER
    MULHOLLAND, B
    FLAXEL, CJ
    HAYES, B
    GREGOR, ZJ
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S132 - S132
  • [13] Systemic treatments for breast cancer brain metastasis
    Chen, Qiuchi
    Xiong, Jie
    Ma, Yuxi
    Wei, Jielin
    Liu, Cuiwei
    Zhao, Yanxia
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [14] PRACTICAL PROTOCOL FOR TREATMENT OF BREAST-CANCER METASTASIS
    BAILLET, F
    JULLIARD, R
    RAYNAL, M
    PIERQUIN, B
    [J]. JOURNAL DE RADIOLOGIE D ELECTROLOGIE ET DE MEDECINE NUCLEAIRE, 1972, 53 (12): : 905 - &
  • [15] BREAST-CANCER - CNS METASTASIS WHILE RECEIVING SYSTEMIC CHEMOTHERAPY
    TRANUM, B
    HOOGSTRATEN, B
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 75 - 75
  • [16] METASTASIS IN BREAST-CANCER
    SCHULZ, KD
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 119 (20) : 750 - 750
  • [17] ASSESSMENT OF RESPONSE OF BONE METASTASES TO SYSTEMIC TREATMENT IN PATIENTS WITH BREAST-CANCER
    COOMBES, RC
    DADY, P
    PARSONS, C
    MCCREADY, VR
    FORD, HT
    GAZET, JC
    POWLES, TJ
    [J]. CANCER, 1983, 52 (04) : 610 - 614
  • [18] Systemic therapy following craniotomy in patients with a solitary breast cancer brain metastasis
    Hulsbergen, Alexander F. C.
    Cho, Logan D.
    Mammi, Marco
    Lamba, Nayan
    Smith, Timothy R.
    Brastianos, Priscilla K.
    Broekman, Marike L. D.
    Lin, Nancy U.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (01) : 147 - 155
  • [19] Systemic therapy following craniotomy in patients with a solitary breast cancer brain metastasis
    Alexander F. C. Hulsbergen
    Logan D. Cho
    Marco Mammi
    Nayan Lamba
    Timothy R. Smith
    Priscilla K. Brastianos
    Marike L. D. Broekman
    Nancy U. Lin
    [J]. Breast Cancer Research and Treatment, 2020, 180 : 147 - 155
  • [20] SUCCESSFULL TREATMENT OF BRAIN METASTASES IN BREAST-CANCER PATIENTS BY HORMONE CHEMOTHERAPY
    MENDE, S
    BLEICHNER, F
    STOETER, P
    MEURET, G
    [J]. ONKOLOGIE, 1983, 6 (02): : 58 - 61
12345